The SBIR and STTR programs are officially on their way back after a five-month hiatus! This is an exciting time but now is not a time for defense startups to celebrate, it is a time to prepare for the colossal opportunity ahead.What Happened and the Makings of the...
Program Overview The Congressionally Directed Medical Research Programs (CDMRP) exists to move high-impact biomedical research forward in areas that matter to Service Members, their families, Veterans, and the broader public, often where traditional funding pathways...
Understanding SBIR/STTR paylines is essential for assessing your funding chances. This guide breaks down current paylines by NIH Institute—including key insights on the NHLBI payline—to help small businesses navigate impact scores, funding thresholds, and strategic opportunities.
Critical info for the 2025 ‘One North Carolina Small Business Program,’ which enables the commercialization of new technologies, while providing more jobs and investment in our respective communities. READ ON:
This report examines the broad economic impact of the SBIR/STTR programs, with a particular focus on the National Cancer Institute (NCI) within NIH.
Calling all small businesses with innovative bioscience in Colorado! Seize a transformative opportunity to propel your early-stage company forward with the Advanced Industries Early-Stage Capital and Retention Grant—right here in the heart of Colorado.
Precision Surgical Interventions Grant Engine is excited to share that Advanced Research Projects Agency for Health (ARPA-H) has officially opened up a specific solution for precision surgical interventions. The Big Question What if surgeries fixed problems...
Grant Engine is excited to share that Advanced Research Projects Agency for Health (ARPA-H) has officially opened up a solicitation. We’ve known the Advanced Research Projects Agency for Health (ARPA-H) would offer non-dilutive funding awards for life science R&D....
Connecting Awardees with Regulatory Experts (CARE): NCI and NHLBI is making progress to support FDA interaction. The CARE program is an innovative collaboration between the National Cancer Institute (NCI) and Food and Drug Administration (FDA) that provides invaluable...
Dear Clients and Partners: Breaking News, 29 Sept 2022: Today, Congress approved and President Biden signed into law the reauthorization of the SBA's SBIR program for an additional three years, through September 2025. Breaking News, 21 Sept 2022: Today, the US Senate...